36E79723R0026_1.docx

DOCX document 17 KB Posted

Attached to
6505--Teriflunomide Tablets Federal contract opportunity
Solicitation number
36E79723R0026
Issued by
Department of Veterans Affairs National Acquisition Center

About this file

This presolicitation notice provides details for solicitation number 36E79723R0026 for teriflunomide tablets. The Department of Veterans Affairs National Acquisition Center intends to issue a request for proposal on August 22, 2023 for an unrestricted procurement of teriflunomide tablets for the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. Offerors must provide the exact brand name and National Drug Code number for the drug to be supplied. The contract period will be one year with four option years. The response date is September 5, 2023. The estimated annual requirements are 11,883 bottles of 14mg teriflunomide tablets and 1,508 bottles of 7mg teriflunomide tablets. The tablets will be distributed through the VA and DOD pharmaceutical prime vendor programs. Interested parties should monitor the listed website for any solicitation amendments.

View the file

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Presolicitation Notice Presolicitation Notice

SUBJECT*
Teriflunomide Tablets

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE*
60141
SOLICITATION NUMBER*
36E79723R0026
RESPONSE DATE/TIME/ZONE
09-05-2023 2:30 PM CENTRAL TIME, CHICAGO, USA
ARCHIVE
99 DAYS AFTER THE RESPONSE DATE

SET-ASIDE

PRODUCT SERVICE CODE*
6505
NAICS CODE*
325412

PLACE OF PERFORMANCE

POSTAL CODE

COUNTRY

CONTACT INFORMATION

CONTRACTING OFFICE ADDRESS
Department of Veterans Affairs

OPAL / National Acquisition Center Building 37 1st Avenue, One Block North of Cermak

POINT OF CONTACT*

Contract Specialist Matthew Poulin Matthew.Poulin@va.gov 708-786-5186

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS
Matthew.Poulin@va.gov
EMAIL DESCRIPTION
Agency POC email

DESCRIPTION

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79723R0026 for an unrestrictive procurement for TERIFLUNOMIDE TABLETS, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA’s and DOD’s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. Solicitation # 36E79723R0026 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about August 22, 2023, with a tentative closing date of September 5, 2023. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: https://sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Matthew Poulin. Questions can be e-mailed to: Matthew.Poulin@va.gov.

The estimated annual requirements are as follows:

ItemDescriptionSizeEst. Annual Requirements
(Tabs Per Bottles)
1. TERIFLUNOMIDE 14MG3011,883
TAB, UNIT OF USE
1. TERIFLUNOMIDE 7MG301,508
TAB, UNIT OF USE
*=Required Field
Presolicitation Notice

Presolicitation Notice

File details come from the government source that posted it. Updated .